We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Assessing Knowledge, Beliefs and Attitudes Toward HPV Vaccination Among Parents in North West, Cameroon

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT05325138
Recruitment Status : Recruiting
First Posted : April 13, 2022
Last Update Posted : April 13, 2022
Sponsor:
Collaborator:
Merck Canada Inc.
Information provided by (Responsible Party):
Lorraine Elit, MD, McMaster University

Tracking Information
First Submitted Date January 10, 2022
First Posted Date April 13, 2022
Last Update Posted Date April 13, 2022
Actual Study Start Date March 14, 2022
Estimated Primary Completion Date January 31, 2023   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: April 12, 2022)
HPV vaccine knowledge, attitudes and beliefs [ Time Frame: 6months ]
Interviews of parents of girls (ages 9-14 years old)
Original Primary Outcome Measures Same as current
Change History No Changes Posted
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title Assessing Knowledge, Beliefs and Attitudes Toward HPV Vaccination Among Parents in North West, Cameroon
Official Title Assessing Knowledge, Beliefs and Attitudes Toward HPV Vaccination Among Parents With Children Aged 9-14yrs Within Rural Communities in North West Region, Cameroon
Brief Summary The aim of this study is to assess knowledge, beliefs and attitudes of parents to young girls aged 9 to 14 years about HPV vaccines within some rural communities in the North West Region of Cameroon served by three hospitals in that area. To do this, we will conduct in-depth qualitative interviews with purposively sampled parents of girls aged 9 to 14 years, some of whom received HPV vaccine and some of whom did not. Interviews will continue until thematic saturation is reached (We anticipate a total 40 interviews). Data analysis will be done concurrently with interviews using thematic analysis.
Detailed Description The aim of this study is to assess knowledge, beliefs and attitudes of parents to young girls aged 9 to 14 years about HPV vaccines within some rural communities in the North West Region of Cameroon served by three hospitals in that area. Snowball sampling technique will be used. Parents of girls aged 9-14years will be included if the daughters have or have not received the HPV vaccine. Exclusion criteria include parents who are health care workers in any health institution, unwilling to provide consent, or inability to converse in English or pidgeon English. In-depth one-on-one interviews will take place using an interview guide. Interviews will be in English or pidgeon English. They will be taped and transcribed. Data will be entered into ATLAS Ti. Data analysis will be done concurrently with interviews using thematic analysis.Interviews will continue until theme saturation is reached (We anticipate a total 40 interviews).
Study Type Observational
Study Design Observational Model: Other
Time Perspective: Other
Target Follow-Up Duration Not Provided
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Parents of girls aged 9-14 years old living in rural north western Cameroon (Mbingo, Njinikom, or Fundong). Their daughters may or may not have received the HPV vaccine.
Condition Vaccine Refusal
Intervention Other: Interview
Parents of girls aged 9-14yearsold will undergo an interview to determine their knowledge, attitudes and beliefs concerning HPV vaccination
Study Groups/Cohorts Parents
Parents of girls aged 9-14 years old
Intervention: Other: Interview
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Recruiting
Estimated Enrollment
 (submitted: April 12, 2022)
45
Original Estimated Enrollment Same as current
Estimated Study Completion Date January 31, 2023
Estimated Primary Completion Date January 31, 2023   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  • Parents of girls aged 9-14 years old living in Mbingo, Njinikom or Fundong health areas of northwestern Cameroon.

Exclusion Criteria:

  • Parents who are health care workers or working in any health institution.
  • Not willing to provide informed consent
  • Not able to converse in English or pidgeon English
Sex/Gender
Sexes Eligible for Study: All
Ages 21 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers Yes
Contacts
Contact: Lorraine M Elit, MD MSc 9055182921 elitl@mcmaster.ca
Contact: Calvin Ngalla, MSc +237 670 24 49 41 ngalla.calvin@yahoo.com
Listed Location Countries Cameroon
Removed Location Countries  
 
Administrative Information
NCT Number NCT05325138
Other Study ID Numbers 100035
Has Data Monitoring Committee No
U.S. FDA-regulated Product
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
IPD Sharing Statement
Plan to Share IPD: No
Plan Description: No IPD sharing is planned
Current Responsible Party Lorraine Elit, MD, McMaster University
Original Responsible Party Same as current
Current Study Sponsor McMaster University
Original Study Sponsor Same as current
Collaborators Merck Canada Inc.
Investigators
Principal Investigator: Lorraine M Elit, MD MSc McMaster University
PRS Account McMaster University
Verification Date April 2022